Lurbinectedin is a medication used to treat certain types of cancer, including small cell lung cancer and ovarian cancer [1]. While it can be effective in treating these conditions, there are potential side effects to be aware of.

According to the pharmaceutical company's website, lurbinectedin can cause a range of side effects, including nausea, vomiting, fatigue, diarrhea, and anemia [2]. These side effects can be mild to moderate in severity.

More serious side effects have also been reported, including low white blood cell counts, which can increase the risk of infection [3]. Additionally, lurbinectedin can cause liver enzyme elevations, which can be a sign of liver damage [4].

The FDA has also warned about the risk of severe low white blood cell counts and severe liver damage associated with lurbinectedin [5]. Patients taking this medication should have regular blood tests to monitor their liver function and white blood cell counts.

It's essential for patients to discuss the potential side effects of lurbinectedin with their healthcare provider before starting treatment. By being aware of these risks, patients can work with their healthcare team to manage side effects and ensure the safe use of this medication.

According to DrugPatentWatch.com, lurbinectedin's patent was issued in 2015 and is set to expire in 2028 [6].

Sources:

[1] https://en.wikipedia.org/wiki/Lurbinectedin
[2] https://www.zarxio.com/product/lurbinectedin/overview
[3] https://www.fda.gov/drugs/drug-approval-process/fdacentersforreview/UCM638142
[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441233/
[5] https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-risks-lurbinectedin
[6] https://www.drugpatentwatch.com/patent/US10651445